• Stifel Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Maintains Target Price $17 富途牛牛 Tue, 07 Jul 2026 07:12:54 GMT
• Have Insiders Sold Lexeo Therapeutics Shares Recently? simplywall.st Fri, 03 Jul 2026 11:19:41 GMT
• Is Lexeo Therapeutics, Inc. (LXEO) Stock Still a Gene Therapy Opportunity After Analyst Valuation Update? Yahoo Finance Thu, 02 Jul 2026 20:06:03 GMT
• Lexeo Therapeutics CMO sells $98,592 in shares By Investing.com Investing.com South Africa Thu, 02 Jul 2026 03:20:29 GMT
• form 144 lexeo therapeutics for: 1 july by investing.com Investing.com India Thu, 02 Jul 2026 00:24:03 GMT
• Lexeo Therapeutics CMO sells $98,592 in shares By Investing.com Investing.com Australia Wed, 01 Jul 2026 23:23:33 GMT
• Lexeo Therapeutics COO Otero sells $20,903 in LXEO stock Investing.com Wed, 01 Jul 2026 23:05:34 GMT
• Form 4 Lexeo Therapeutics Inc For: 1 July By Investing.com Investing.com Canada Wed, 01 Jul 2026 23:02:08 GMT
• RSU grant and tax-cover share sale by Lexeo (LXEO) chief financial officer Stock Titan Wed, 01 Jul 2026 22:50:07 GMT
• Lexeo Therapeutics (LXEO) COO reports stock award and small tax-related sale Stock Titan Wed, 01 Jul 2026 22:49:33 GMT
• Lexeo Therapeutics (LXEO) CMO awarded 55K shares and sells 22K to cover RSU taxes Stock Titan Wed, 01 Jul 2026 22:48:53 GMT
• Lexeo Therapeutics (LXEO) CEO logs RSU grant and tax-driven share sale Stock Titan Wed, 01 Jul 2026 22:47:46 GMT
• LXEO (NASDAQ) Form 144: Proposed resale of 4,666 vested shares via Fidelity Stock Titan Wed, 01 Jul 2026 20:54:44 GMT
• Form 144 Lexeo Therapeutics For: 1 July By Investing.com Investing.com Canada Wed, 01 Jul 2026 20:52:06 GMT
• LXEO (NASDAQ: LXEO) director files Form 144 proposing sale of 25,947 shares Stock Titan Wed, 01 Jul 2026 20:42:25 GMT
• 5 best up and coming pharmaceutical stocks to buy now Insider Monkey Wed, 01 Jul 2026 04:11:17 GMT
• Form 4 Lexeo Therapeutics Inc For: 29 June By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 22:08:27 GMT
• Lexeo Therapeutics (NASDAQ: LXEO) investors approve directors and ratify KPMG auditor Stock Titan Mon, 29 Jun 2026 21:06:46 GMT
• Lexeo Therapeutics (LXEO) director receives grant of 35,000 stock options at $4.70 Stock Titan Mon, 29 Jun 2026 20:41:19 GMT
• Lexeo Therapeutics (LXEO) director awarded 35,000 stock options at $4.70 Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics (LXEO) director awarded options on 35,000 shares at $4.70 Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics (LXEO) director receives 35,000 options at $4.70 Stock Titan Mon, 29 Jun 2026 07:00:00 GMT
• price to sales forward of lexeo therapeutics, inc. – nasdaq:lxeo TradingView Fri, 26 Jun 2026 05:58:54 GMT
• price to book forward of lexeo therapeutics, inc. – nasdaq:lxeo TradingView Fri, 26 Jun 2026 05:58:20 GMT
• price to earnings forward of lexeo therapeutics, inc. – nasdaq:lxeo TradingView Fri, 26 Jun 2026 03:31:52 GMT
• enterprise value to ebitda forward of lexeo therapeutics, inc. – nasdaq:lxeo TradingView Fri, 26 Jun 2026 02:50:59 GMT
• enterprise value to ebit forward of lexeo therapeutics, inc. – nasdaq:lxeo TradingView Fri, 26 Jun 2026 02:50:48 GMT
• LXEO Maintained by JP Morgan -- Price Target Lowered to $9.00 GuruFocus Thu, 25 Jun 2026 16:37:48 GMT
• lexeo therapeutics price target cut to $9.00/share from $12.00 by jp morgan Moomoo Thu, 25 Jun 2026 15:00:00 GMT
• J.P. Morgan Maintains Lexeo Therapeutics(LXEO.US) With Buy Rating, Announces Target Price $9 Moomoo Thu, 25 Jun 2026 12:31:00 GMT
• Lexeo Therapeutics’s LX2006 Has A Viable Regulatory Pathway And Timeline (NASDAQ:LXEO) Seeking Alpha Mon, 22 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics advances gene therapy LX2006 for Friedreich's ataxia cardiomyopathy with promising early data. Pluang Mon, 22 Jun 2026 07:00:00 GMT
• lexeo therapeutics inc (lxeo) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• lexeo therapeutics shares climb following fda breakthrough therapy designation MSN Fri, 19 Jun 2026 02:30:44 GMT
• Lexeo Therapeutics Inc (LXEO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 14:53:32 GMT
• lexeo therapeutics inc (lxeo) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 10:02:00 GMT
• insiders in lexeo therapeutics left out from 21% price rise after disposing stock 富途牛牛 Thu, 18 Jun 2026 07:00:00 GMT
• lexeo therapeutics inc (lxeo) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 06:42:10 GMT
• lexeo therapeutics inc (lxeo) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 06:25:22 GMT
• lexeo therapeutics inc (lxeo) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 06:23:28 GMT
• lexeo therapeutics inc (lxeo) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 06:19:19 GMT
• lexeo therapeutics publishes phase i/ii data for lx2006 in friedreich ataxia in jama cardiology marketscreener.com Wed, 17 Jun 2026 20:01:00 GMT
• lexeo therapeutics inc (lxeo) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 19:58:16 GMT
• lexeo therapeutics inc (lxeo) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 19:58:03 GMT
• Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia GlobeNewswire Wed, 17 Jun 2026 07:00:00 GMT
• Lexeo’s gene therapy shows early cardiac, neurologic signals in FA Stock Titan Wed, 17 Jun 2026 07:00:00 GMT
• Lexeo publishes phase I/II data for gene therapy LX2006 Investing.com Wed, 17 Jun 2026 07:00:00 GMT
• lxeo: pivotal lx2006 trial in fa to start, targeting lvmi reduction with accelerated approval path TradingView Mon, 15 Jun 2026 13:58:03 GMT
• lexeo therapeutics advances sunrise-fa 2 pivotal trial for gene therapy lx2006 in friedreich ataxia cardiomyopathy Quiver Quantitative Mon, 15 Jun 2026 11:12:00 GMT
• lexeo's gene therapy forges a rapid new path for rare heart disease BriefGlance Mon, 15 Jun 2026 11:00:00 GMT
• Gene therapy trial aims to tackle Friedreich ataxia heart damage Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics (Nasdaq: LXEO) maps LX2006 pivotal trial, 2027 data and 2028 BLA bid Stock Titan Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics Finalizes Study Design for Friedreich Ataxia Gene Therapy Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics (LXEO) Advances Gene Therapy Trial for Friedr GuruFocus Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo finalizes SUNRISE-FA 2 pivotal design for LX2006; topline data due 2H 2027, BLA targeted 1H 2028 TradingView Mon, 15 Jun 2026 07:00:00 GMT
• LXEO: Pivotal LX2006 study set for Q2 2026, aiming for accelerated approval and BLA in 1H 2028 TradingView Mon, 15 Jun 2026 07:00:00 GMT
• LXEO: Pivotal LX2006 trial in FA finalized, aiming for accelerated approval with strong early data TradingView Mon, 15 Jun 2026 07:00:00 GMT
• LXEO: Pivotal trial for LX2006 in Friedreich ataxia set for Q2 2026, targeting BLA in 2028 TradingView Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo finalizes pivotal trial design for gene therapy LX2006 By Investing.com Investing.com Canada Mon, 15 Jun 2026 07:00:00 GMT
• Lexeo Therapeutics announced that the launch of its Sunrise-Fa 2 project is progressing steadily as planned, with the goal of comp... Bitget Mon, 15 Jun 2026 07:00:00 GMT
• lexeo therapeutics finalizes sunrise-fa 2 pivotal trial protocol and statistical analysis plan for lx2006 gene therapy in friedrei... marketscreener.com Mon, 15 Jun 2026 07:00:00 GMT
• lexeo therapeutics, inc. (lxeo) shareholder/analyst call - slideshow (nasdaq:lxeo) 2026-06-15 Seeking Alpha Mon, 15 Jun 2026 07:00:00 GMT
• lexeo therapeutics (lxeo) edges higher, holds above key support after modest gain - throwback trade dars.gov.et Tue, 09 Jun 2026 07:00:00 GMT
• cantor fitzgerald initiates coverage of lexeo therapeutics (lxeo) with overweight recommendation MSN Mon, 08 Jun 2026 13:35:45 GMT
• Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation simplywall.st Wed, 03 Jun 2026 07:00:00 GMT
• lexeo therapeutics (lxeo) edges higher as stock tests support zone near $4.30 - quality factor dars.gov.et Wed, 03 Jun 2026 07:00:00 GMT
• stifel maintains lexeo therapeutics(lxeo.us) with buy rating, cuts target price to $17 富途牛牛 Tue, 26 May 2026 02:27:03 GMT
• lexeo therapeutics q1 2026 earnings: eps beat on lower operating costs - post-earnings drift newsline.com Sat, 23 May 2026 07:00:00 GMT
• top executive makes notable move in lexeo therapeutics stock TipRanks Thu, 21 May 2026 02:11:11 GMT
• lexeo (lxeo) coo sells 1,302 shares in tax-related stock sale Stock Titan Wed, 20 May 2026 07:00:00 GMT
• lexeo therapeutics (lxeo) ceo sells 3,342 shares in tax-related rsu transaction Stock Titan Wed, 20 May 2026 07:00:00 GMT
• Lexeo Therapeutics to Participate in the 2026 RBC Capital Markets Global Healthcare Conference Yahoo Finance Tue, 19 May 2026 07:00:00 GMT
• biotech lexeo joins rbc 2026 healthcare fireside chat, live webcast Stock Titan Tue, 19 May 2026 07:00:00 GMT
• lxeo (nasdaq: lxeo) insider sale notice — 1,595 vested shares Stock Titan Mon, 18 May 2026 07:00:00 GMT
• lxeo (nasdaq: lxeo) lists restricted stock vesting; form 144 shows past sale Stock Titan Mon, 18 May 2026 07:00:00 GMT
• lxeo (nasdaq:lxeo) rule 144 notice: 3,342 vested shares; prior sale 10,173 Stock Titan Mon, 18 May 2026 07:00:00 GMT
• paradigm biocapital holds 6.18m lexeo shares (lxeo); 8.3% stake reported Stock Titan Fri, 15 May 2026 20:25:34 GMT
• balyasny groups disclose 7.18m shares in lexeo therapeutics (lxeo) Stock Titan Fri, 15 May 2026 07:00:00 GMT
• lexeo therapeutics, inc. (lxeo) eps diluted (ttm) Zacks Investment Research Thu, 14 May 2026 00:40:59 GMT
• lexeo therapeutics price target maintained with a $17.00/share by chardan capital Moomoo Tue, 12 May 2026 20:18:43 GMT
• analysts offer insights on healthcare companies: bioage labs, inc. (bioa) and lexeo therapeutics, inc. (lxeo) The Globe and Mail Tue, 12 May 2026 18:32:55 GMT
• rbc capital maintains lexeo therapeutics(lxeo.us) with buy rating, maintains target price $20 富途牛牛 Tue, 12 May 2026 07:00:00 GMT
• stifel maintains lexeo therapeutics(lxeo.us) with buy rating, cuts target price to $17 Moomoo Tue, 12 May 2026 07:00:00 GMT
• raymond james reiterates strong buy on lexeo stock, $25 target by investing.com Investing.com Australia Tue, 12 May 2026 07:00:00 GMT
• chardan capital maintains lexeo therapeutics(lxeo.us) with buy rating, maintains target price $17 富途牛牛 Mon, 11 May 2026 21:36:04 GMT
• lexeo therapeutics price target maintained with a $17.00/share by chardan capital Moomoo Mon, 11 May 2026 18:06:00 GMT
• lexeo therapeutics, inc. q1 2026 10-q report: financial results, forward-looking statements, and key disclosures Minichart Mon, 11 May 2026 18:04:00 GMT
• lexeo therapeutics (nasdaq: lxeo) posts lower q1 loss with $227.6m cash Stock Titan Mon, 11 May 2026 11:05:02 GMT
• lexeo therapeutics (lxeo) price target increased by 19.77% to 21.29 MSN Mon, 11 May 2026 10:14:31 GMT
• Lexeo Therapeutics Reports First Quarter 2026 Financial Results and Operational Highlights GlobeNewswire Mon, 11 May 2026 07:00:00 GMT
• raymond james reiterates strong buy on lexeo stock, $25 target Investing.com Mon, 11 May 2026 07:00:00 GMT
• lexeo readies friedreich ataxia pivotal trial, cash runway into 2028 Stock Titan Mon, 11 May 2026 07:00:00 GMT
• press release: lexeo therapeutics reports first quarter 2026 financial results and operational highlights Moomoo Mon, 11 May 2026 07:00:00 GMT
• why lexeo therapeutics (lxeo) looks attractive at current levels (parabolic) 2026-05-11 - low vol factor newsline.com Mon, 11 May 2026 07:00:00 GMT
• lexeo therapeutics, inc. 1q 2026: net income $(20.2m), eps $(0.25) — 10-q summary TradingView Mon, 11 May 2026 07:00:00 GMT
• lexeo therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Mon, 11 May 2026 07:00:00 GMT
• chardan capital reaffirms "buy" rating for lexeo therapeutics (nasdaq:lxeo) MarketBeat Mon, 11 May 2026 07:00:00 GMT
• lexeo therapeutics reports q1 2026 results, advances cardiac gene therapy pipeline, and awaits fda feedback on pivotal trial Minichart Mon, 11 May 2026 07:00:00 GMT
• lexeo (nasdaq: lxeo) trims q1 loss and advances pivotal cardiac gene therapy plans Stock Titan Mon, 11 May 2026 07:00:00 GMT
• lexeo therapeutics (nasdaq:lxeo) announces earnings results MarketBeat Mon, 11 May 2026 07:00:00 GMT
• lexeo highlights q1 progress advancing cardiac gene therapies TipRanks Mon, 11 May 2026 07:00:00 GMT
• lexeo therapeutics inc expected to post a loss of 31 cents a share - earnings preview TradingView Fri, 08 May 2026 20:20:12 GMT
• lxeo: lexeo therapeutics, inc. - interactive chart Zacks Investment Research Fri, 08 May 2026 04:25:43 GMT
• the scenario planning at lexeo therapeutics (lxeo) | q4 2025: eps beats forecasts - return on capital newsline.com Wed, 06 May 2026 07:00:00 GMT
• lexeo therapeutics (lxeo) expected to announce quarterly earnings on monday MarketBeat Mon, 04 May 2026 07:00:00 GMT
• lexeo therapeutics (nasdaq:lxeo) lowered to "sell" rating by wall street zen MarketBeat Sat, 02 May 2026 07:00:00 GMT
• [form 4] lexeo therapeutics, inc. insider trading activity Stock Titan Thu, 30 Apr 2026 20:01:55 GMT
• lexeo therapeutics (lxeo) director receives 50,000 stock options at $5.81 strike Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• lexeo therapeutics (lxeo) director laura sepp-lorenzino files form 3 Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• dr. laura sepp-lorenzino joins lexeo therapeutics (lxeo) board and science committee Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• lexeo therapeutics (nasdaq: lxeo) details 2026 virtual meeting, board elections and pay Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• lexeo therapeutics announces multiple presentations at the 29th american society of gene & cell therapy (asgct) annual meeting The Manila Times Tue, 28 Apr 2026 07:00:00 GMT
• Lexeo Therapeutics Announces Multiple Presentations at the GlobeNewswire Mon, 27 Apr 2026 07:00:00 GMT
• Lexeo brings Friedreich ataxia, heart gene therapy data to Boston Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• lexeo therapeutics to present new cardiac gene therapy data at asgct annual meeting 2026 Quiver Quantitative Mon, 27 Apr 2026 07:00:00 GMT
• we think lexeo therapeutics (nasdaq:lxeo) needs to drive business growth carefully Moomoo Sat, 25 Apr 2026 07:00:00 GMT
• lxeo sec filings - lexeo therapeutics inc 10-k, 10-q, 8-k forms Stock Titan Wed, 22 Apr 2026 13:08:03 GMT
• is lexeo therapeutics (lxeo) stock a good candidate for accumulation (volatility increases) 2026-04-20 - social buy zones UBND thành phố Hải Phòng Mon, 20 Apr 2026 16:30:39 GMT
• h.c. wainwright maintains lexeo therapeutics(lxeo.us) with buy rating, maintains target price $22 富途牛牛 Sat, 18 Apr 2026 05:41:02 GMT
Lexeo Therapeutics, Inc.(NASDAQ:LXEO) 
Lexeo Therapeutics, Inc. operates as a clinical stage genetic medicine company that focuses on hereditary and acquired diseases. The company develops LX2006, which is an AAVrh10-based gene therapy candidate for the treatment of Friedreich's ataxia (FA) cardiomyopathy; LX2020, an AAVrh10-based gene t...
Website: https://www.lexeotx.com/
Founded: 2017
IPO Price: $11 (Nov 13, 2023)
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends